Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration

Troels Brynskov; Inger Christine Munch; Tobias Larsen; Liv  Erngaard; Torben Lykke Sørensen

Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration

Troels Brynskov, Inger Christine Munch, Tobias Larsen, Liv Erngaard, Torben Lykke Sørensen

Department of Clinical Medicine

Original language	English
Journal	Acta Ophthalmologica
ISSN	1755-375X
Publication status	Accepted/In press - 11 Jun 2019

Cite this

@article{a985933707194d7f8dd14b60afe277fc,

title = "Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration",

author = "Troels Brynskov and Munch, {Inger Christine} and Tobias Larsen and Liv Erngaard and S{\o}rensen, {Torben Lykke}",

year = "2019",

month = jun,

day = "11",

language = "English",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration

AU - Brynskov, Troels

AU - Munch, Inger Christine

AU - Larsen, Tobias

AU - Erngaard, Liv

AU - Sørensen, Torben Lykke

PY - 2019/6/11

Y1 - 2019/6/11

M3 - Journal article

SN - 1755-375X

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

ER -